hsa04010 |
MAPK signaling pathway |
78/514 |
4.11E-29 |
5.01E-27 |
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications |
43/514 |
1.00E-25 |
3.07E-24 |
hsa04151 |
PI3K-Akt signaling pathway |
81/514 |
1.78E-25 |
3.78E-24 |
hsa04668 |
TNF signaling pathway |
40/514 |
2.03E-20 |
2.26E-19 |
hsa04657 |
IL-17 signaling pathway |
35/514 |
1.11E-18 |
9.45E-18 |
hsa01521 |
EGFR tyrosine kinase inhibitor resistance |
32/514 |
1.81E-18 |
1.38E-17 |
hsa04659 |
Th17 cell differentiation |
36/514 |
1.65E-17 |
1.06E-16 |
hsa04066 |
HIF-1 signaling pathway |
36/514 |
3.29E-17 |
2.01E-16 |
hsa04210 |
Apoptosis |
40/514 |
5.52E-17 |
3.06E-16 |
hsa01522 |
Endocrine resistance |
33/514 |
3.70E-16 |
1.88E-15 |
hsa04014 |
Ras signaling pathway |
50/514 |
8.04E-15 |
3.50E-14 |
hsa04625 |
C-type lectin receptor signaling pathway |
31/514 |
1.33E-13 |
4.79E-13 |
hsa04660 |
T cell receptor signaling pathway |
31/514 |
1.33E-13 |
4.79E-13 |
hsa04810 |
Regulation of actin cytoskeleton |
45/514 |
4.88E-13 |
1.53E-12 |
hsa04015 |
Rap1 signaling pathway |
44/514 |
1.03E-12 |
3.13E-12 |
hsa04919 |
Thyroid hormone signaling pathway |
32/514 |
2.04E-12 |
5.93E-12 |
hsa04620 |
Toll-like receptor signaling pathway |
29/514 |
5.39E-12 |
1.46E-11 |
hsa04218 |
Cellular senescence |
36/514 |
6.71E-12 |
1.74E-11 |
hsa04062 |
Chemokine signaling pathway |
40/514 |
8.30E-12 |
2.07E-11 |
hsa04020 |
Calcium signaling pathway |
41/514 |
1.57149E-11 |
3.76249E-11 |